Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 10 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-07 Sonsini Peter W. 10% owner Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 SANDELL SCOTT D 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 SANDELL SCOTT D 10% owner Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 MOTT DAVID M Director Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 MOTT DAVID M Director Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 KERINS PATRICK J 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 Florence Anthony A. Jr. 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 Florence Anthony A. Jr. 10% owner Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 Behbahani Ali Director Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 BASKETT FOREST 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 BASKETT FOREST 10% owner Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 BARRIS PETER J 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 BARRIS PETER J 10% owner Purchase +12,000,000 $1.67 $20.0M 12,000,000
2018-09-07 BARRETT M JAMES 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-09-07 New Enterprise Associates 14, L.P. 10% owner Purchase +3,000,000 $1.67 $5.0M 82,978,668
2018-08-29 Binder-Scholl Gwendolyn Knowlton Chief Technology Officer Sale −25,000 $10.25 $256K 0
2018-08-06 Amado Rafael President, R & D Grant or award · Option to purchase Ordinary Shares +678,720 678,720
2018-06-22 MOTT DAVID M Director Grant or award · Option to purchase Ordinary Shares +187,330 187,330
2018-06-22 Behbahani Ali Director Grant or award · Option to purchase Ordinary Shares +154,809 154,809
2018-06-22 Alleva Lawrence M Director Grant or award · Option to purchase Ordinary Shares +124,000 124,000

Page 17 of 23 · 454 trades